$Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system$

Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system

Mona Al-Ahmad,1 Maryam S Alowayesh,2 Norman V Carroll31Microbiology Department, Faculty of Medicine, 2Pharmacy Practice Department, Faculty of Pharmacy, Kuwait University, Kuwait; 3Division of Pharmacoeconomics and Health Outcomes, School of Pharmacy, Virginia Commonwealth University, VA, USABackgro...

Full description

Bibliographic Details
Main Authors:	Al-Ahmad M, Alowayesh MS, Carroll NV
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-05-01
Series:	ClinicoEconomics and Outcomes Research
Subjects:	Cost chronic urticaria Kuwait Omalizumab Economic Middle East
Online Access:	https://www.dovepress.com/economic-burden-of-refractory-chronic-spontaneous-urticaria-on-kuwait3-peer-reviewed-article-CEOR

Similar Items

Role of omalizumab in refractory chronic spontaneous urticaria: A single referral center experience
by: Gautam Kumar Singh, et al.
Published: (2018-01-01)

The use of an urticaria control test for the evaluation of omalizumab treatment response in patients diagnosed with chronic urticaria
by: Burhan Engin, et al.
Published: (2020-12-01)

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
by: Kiran Godse, et al.
Published: (2016-01-01)

The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations
by: Mario Sánchez-Borges, et al.
Published: (2021-06-01)

The effect of omalizumab treatment on IgE and other immunoglobulin levels in patients with chronic spontaneous urticaria and its association with treatment response
by: Songül Çildağ, et al.
Published: (2018-07-01)

Omalizumab for management of refractory urticaria: Experience of a tertiary care centre in Eastern India
by: Shekhar Neema, et al.
Published: (2018-01-01)

Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
by: Eli Magen
Published: (2019-07-01)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
by: Yudi Chen, et al.
Published: (2021-01-01)

Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016-02-01)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
by: Shuang-Lu Liao, et al.
Published: (2021-03-01)

Current approaches to the treatment of frequently recurrent urticaria.
by: E. M. Dytyatkovska, et al.
Published: (2019-12-01)

Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
by: Che-Wen Yang, et al.
Published: (2017-12-01)

Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
by: Laura Michelina Losappio, et al.
Published: (2020-10-01)

Plasma D-dimer as a biomarker of chronic urticaria treatment
by: Mohamed Metwalli, et al.
Published: (2019-01-01)

The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
by: Mario Sánchez-Borges, et al.
Published: (2021-06-01)

CHRONIC AUTOIMMUNE URTICARIA IN CHILDREN
by: Lana Stergar, et al.
Published: (2021-03-01)

Adverse Reaction to Omalizumab in Patients with Chronic Urticaria: Flare Up or Ineffectiveness?
by: Ragıp Ertaş, et al.
Published: (2016-01-01)

Systemic and local evidence for complement involvement in chronic spontaneous urticaria
by: Mehran Alizadeh Aghdam, et al.
Published: (2021-07-01)

Omalizumab (Xolair) in Children Above 12 Years With Chronic Urticaria: A Review of Literature
by: Javad Ghaffari, et al.
Published: (2015-01-01)

Omalizumab (Xolair) in Children Above 12 Years With Chronic Urticaria: A Review of Literature
by: Javad Ghaffari, et al.
Published: (2015-01-01)

Safety of Methotrexate in Chronic Urticaria Unresponsive to Omalizumab
by: Mehmet Unsel
Published: (2021-08-01)

Chronic Spontaneous Urticaria: A Review of Pathological Mechanisms, Diagnosis, Clinical Management, and Treatment
by: Victor Desmond Mandel, et al.
Published: (2020-03-01)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
by: Pasquale Comberiati, et al.
Published: (2019-07-01)

The effect of COVID-19 pandemic on treatment compliance and process of chronic urticaria patients receiving omalizumab treatment
by: Gokhan Aytekin, et al.
Published: (2021-09-01)

Treatment of chronic spontaneous urticaria with a single dose of omalizumab: A study of four cases
by: Radhakrishnan Subramaniyan, et al.
Published: (2016-01-01)

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
by: Ilya Ivyanskiy, et al.
Published: (2012-01-01)

Omalizumab for treatment of chronic urticaria: A review of effective dose
by: javad Ghaffari, et al.
Published: (2019-03-01)

Utilidad clínica del omalizumab en urticaria crónica inducible
by: Ricardo Cardona
Published: (2018-06-01)

Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study
by: Chia-Yu Chu, et al.
Published: (2020-04-01)

Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
by: Vera G. Kalugina, et al.
Published: (2020-08-01)

Ciclosporina no Tratamento da Urticária Crónica Espontânea na Era do Omalizumab
by: Bárbara Roque Ferreira, et al.
Published: (2018-05-01)

Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?
by: Atıl Avcı, et al.
Published: (2019-02-01)

Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn’s Disease
by: Simona Barni, et al.
Published: (2021-03-01)

Successful Treatment of Chronic Spontaneous Urticaria Associated with Autoimmune Thyroiditis: Clinical Case
by: Vera G. Kalugina, et al.
Published: (2019-12-01)

Recomendaciones para el diagnóstico, clasificación y el manejo de la urticaria
by: Giovanni Sedó-Mejía, et al.
Published: (2015-09-01)

Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice
by: Vollono L, et al.
Published: (2019-09-01)

Can We Predict the Duration of Treatment Requirement by Complete Blood Count in Chronic Spontaneous Urticaria Patients Receiving Omalizumab?
by: Ebru Celik, et al.
Published: (2020-09-01)

Effects of omalizumab therapy on peripheral nerve functions: short observational study
by: Goknur Yavuz, et al.
Published: (2018-04-01)

Treatment of Severe Cold Contact Urticaria with Omalizumab: Case Reports
by: Petra Brodská, et al.
Published: (2012-12-01)

Definition of Recurrent Chronic Spontaneous Urticaria
by: Gemma Melé-Ninot, et al.
Published: (2020-09-01)